1 – 10 of 39
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Antiviral tablettbehandling av covid-19 – ett värdefullt tillskott
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
COVID-19 hospitalization outcomes in adults by HIV status; a nation-wide register-based study
2023) In HIV Medicine(
- Contribution to journal › Article
-
Mark
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure - two nationwide, population-based cohort studies
(
- Contribution to journal › Article
-
Mark
Cohort profile: InfCareHIV, a prospective registry-based cohort study of people with diagnosed HIV in Sweden
(
- Contribution to journal › Article
- 2022
-
Mark
Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy : A Swedish observational study
(
- Contribution to journal › Article
-
Mark
Associations between HIV viremia during antiretroviral therapy and cardiovascular disease
(
- Contribution to journal › Article
-
Mark
COVID-19 in people aged 18–64 in Sweden in the first year of the pandemic : Key factors for severe disease and death
(
- Contribution to journal › Article
-
Mark
Severe COVID-19 in people 55 and older during the first year of the pandemic in Sweden
(
- Contribution to journal › Article
-
Mark
Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls
(
- Contribution to journal › Article
-
Mark
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome : No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
(
- Contribution to journal › Article